CompletedPhase 3

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT00097877

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Novo Nordisk Investigational Site

Birmingham, Alabama, United States

+72 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2005-01
Enrollment: 293 participants
Sponsor: Novo Nordisk A/S
Purpose: treatment

Locations (73)

Novo Nordisk Investigational SiteBirmingham, Alabama, United States
Novo Nordisk Investigational SiteTuscaloosa, Alabama, United States
Novo Nordisk Investigational SiteVestavia Hills, Alabama, United States
Novo Nordisk Investigational SiteSearcy, Arkansas, United States
Novo Nordisk Investigational SiteChula Vista, California, United States
Novo Nordisk Investigational SiteFullerton, California, United States
Novo Nordisk Investigational SiteOrange, California, United States
Novo Nordisk Investigational SiteOrange, California, United States
Novo Nordisk Investigational SiteNew Britain, Connecticut, United States
Novo Nordisk Investigational SiteAventura, Florida, United States
Novo Nordisk Investigational SiteChiefland, Florida, United States
Novo Nordisk Investigational SiteFort Myers, Florida, United States
Novo Nordisk Investigational SiteJacksonville, Florida, United States
Novo Nordisk Investigational SiteMelbourne, Florida, United States
Novo Nordisk Investigational SiteOcala, Florida, United States
Novo Nordisk Investigational SitePlantation, Florida, United States
Novo Nordisk Investigational SiteAtlanta, Georgia, United States
Novo Nordisk Investigational SiteAtlanta, Georgia, United States
Novo Nordisk Investigational SiteBoise, Idaho, United States
Novo Nordisk Investigational SiteChicago, Illinois, United States
Novo Nordisk Investigational SiteNew Albany, Indiana, United States
Novo Nordisk Investigational SiteDes Moines, Iowa, United States
Novo Nordisk Investigational SiteOverland Park, Kansas, United States
Novo Nordisk Investigational SiteTopeka, Kansas, United States
Novo Nordisk Investigational SiteBaton Rouge, Louisiana, United States
Novo Nordisk Investigational SiteBaltimore, Maryland, United States
Novo Nordisk Investigational SiteSpringfield, Massachusetts, United States
Novo Nordisk Investigational SiteChesterfield, Missouri, United States
Novo Nordisk Investigational SiteSt Louis, Missouri, United States
Novo Nordisk Investigational SiteSt Louis, Missouri, United States
Novo Nordisk Investigational SiteOmaha, Nebraska, United States
Novo Nordisk Investigational SiteLas Vegas, Nevada, United States
Novo Nordisk Investigational SiteCherry Hill, New Jersey, United States
Novo Nordisk Investigational SiteLawrenceville, New Jersey, United States
Novo Nordisk Investigational SitePlainsboro, New Jersey, United States
Novo Nordisk Investigational SiteNew Hyde Park, New York, United States
Novo Nordisk Investigational SiteStaten Island, New York, United States
Novo Nordisk Investigational SiteSyracuse, New York, United States
Novo Nordisk Investigational SiteGreensboro, North Carolina, United States
Novo Nordisk Investigational SiteDayton, Ohio, United States
Novo Nordisk Investigational SiteDayton, Ohio, United States
Novo Nordisk Investigational SiteKettering, Ohio, United States
Novo Nordisk Investigational SiteClinton, Oklahoma, United States
Novo Nordisk Investigational SiteTulsa, Oklahoma, United States
Novo Nordisk Investigational SiteEugene, Oregon, United States
Novo Nordisk Investigational SitePortland, Oregon, United States
Novo Nordisk Investigational SiteSalem, Oregon, United States
Novo Nordisk Investigational SiteLancaster, Pennsylvania, United States
Novo Nordisk Investigational SiteMelrose Park, Pennsylvania, United States
Novo Nordisk Investigational SiteNorristown, Pennsylvania, United States
Novo Nordisk Investigational SiteWest Reading, Pennsylvania, United States
Novo Nordisk Investigational SiteGreer, South Carolina, United States
Novo Nordisk Investigational SiteMemphis, Tennessee, United States
Novo Nordisk Investigational SiteArlington, Texas, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteDallas, Texas, United States
Novo Nordisk Investigational SiteHouston, Texas, United States
Novo Nordisk Investigational SiteLewisville, Texas, United States
Novo Nordisk Investigational SiteMidland, Texas, United States
Novo Nordisk Investigational SitePlano, Texas, United States
Novo Nordisk Investigational SitePlano, Texas, United States
Novo Nordisk Investigational SiteSan Antonio, Texas, United States
Novo Nordisk Investigational SiteOgden, Utah, United States
Novo Nordisk Investigational SiteNewport News, Virginia, United States
Novo Nordisk Investigational SiteRichmond, Virginia, United States
Novo Nordisk Investigational SiteWarrenton, Virginia, United States
Novo Nordisk Investigational SiteBellevue, Washington, United States
Novo Nordisk Investigational SiteMilwaukee, Wisconsin, United States
Novo Nordisk Investigational SiteManati, Puerto Rico
Novo Nordisk Investigational SiteSanturce, Puerto Rico